Suppr超能文献

孕期抗心律失常药物

Antiarrhythmic drugs in pregnancy.

作者信息

Joglar J A, Page R L

机构信息

The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.

出版信息

Curr Opin Cardiol. 2001 Jan;16(1):40-5. doi: 10.1097/00001573-200101000-00006.

Abstract

During pregnancy a number of rhythm disturbances can occur in both the mother and fetus; these may range from benign ectopy to life-threatening arrhythmias. With a clear understanding of the maternal hemodynamic changes associated with pregnancy, and the appropriate antiarrhythmic therapies available, almost all such cases can be treated successfully. Although no drug is completely safe, most are well tolerated and can be given with relatively low risk. Drug therapy should be avoided during the first trimester of pregnancy if possible and drugs with the longest record of safety should be used as first-line therapy. Conservative therapies should be used when appropriate. Several drug options exist for most maternal and fetal arrhythmias.

摘要

在怀孕期间,母亲和胎儿都可能出现一些节律紊乱;这些紊乱的范围可能从良性异位心律到危及生命的心律失常。清楚了解与怀孕相关的母体血流动力学变化以及可用的适当抗心律失常疗法后,几乎所有此类病例都能得到成功治疗。虽然没有一种药物是完全安全的,但大多数药物耐受性良好,使用风险相对较低。如果可能,在怀孕的头三个月应避免药物治疗,应使用安全性记录最长的药物作为一线治疗。应在适当的时候采用保守疗法。对于大多数母体和胎儿心律失常,有几种药物可供选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验